 |
PDBsum entry 2hoc
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Lyase
|
 |
|
Title:
|
 |
Crystal structure of the human carbonic anhydrase ii in complex with the 5-(4-amino-3-chloro-5-fluorophenylsulfonamido)-1,3,4-thiadiazole- 2-sulfonamide inhibitor
|
|
Structure:
|
 |
Carbonic anhydrase 2. Chain: a. Synonym: carbonic anhydrase ii, carbonate dehydratase ii, ca-ii, carbonic anhydrasE C. Ec: 4.2.1.1
|
|
Source:
|
 |
Homo sapiens. Human. Organism_taxid: 9606. Other_details: human erythrocytes
|
|
Resolution:
|
 |
|
2.10Å
|
R-factor:
|
0.184
|
R-free:
|
0.223
|
|
|
Authors:
|
 |
V.Menchise,A.Di Fiore,G.De Simone
|
|
Key ref:
|
 |
V.Menchise
et al.
(2006).
Carbonic anhydrase inhibitors: X-ray crystallographic studies for the binding of 5-amino-1,3,4-thiadiazole-2-sulfonamide and 5-(4-amino-3-chloro-5-fluorophenylsulfonamido)-1,3,4-thiadiazole-2-sulfonamide to human isoform II.
Bioorg Med Chem Lett,
16,
6204-6208.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
14-Jul-06
|
Release date:
|
10-Oct-06
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
P00918
(CAH2_HUMAN) -
Carbonic anhydrase 2 from Homo sapiens
|
|
|
|
Seq: Struc:
|
 |
 |
 |
260 a.a.
258 a.a.
|
|
|
|
|
|
|
|
|
 |
 |
|
|
Key: |
 |
PfamA domain |
 |
 |
 |
Secondary structure |
 |
 |
CATH domain |
 |
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
E.C.4.2.1.1
- carbonic anhydrase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
hydrogencarbonate + H+ = CO2 + H2O
|
 |
 |
 |
 |
 |
hydrogencarbonate
|
+
|
H(+)
|
=
|
CO2
|
+
|
H2O
|
|
 |
 |
 |
 |
 |
 |
 |
 |
Cofactor:
|
 |
Zn(2+)
|
 |
 |
 |
 |
 |
 |
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
DOI no:
|
Bioorg Med Chem Lett
16:6204-6208
(2006)
|
|
PubMed id:
|
|
|
|
|
| |
|
Carbonic anhydrase inhibitors: X-ray crystallographic studies for the binding of 5-amino-1,3,4-thiadiazole-2-sulfonamide and 5-(4-amino-3-chloro-5-fluorophenylsulfonamido)-1,3,4-thiadiazole-2-sulfonamide to human isoform II.
|
|
V.Menchise,
G.De Simone,
A.Di Fiore,
A.Scozzafava,
C.T.Supuran.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The X-ray crystal structures of 5-amino-1,3,4-thiadiazole-2-sulfonamide (the
acetazolamide precursor) and
5-(4-amino-3-chloro-5-fluorophenylsulfonamido)-1,3,4-thiadiazole-2-sulfonamide
in complex with the human isozyme II of carbonic anhydrase (CA, EC 4.2.1.1) are
reported. The thiadiazole-sulfonamide moiety of the two compounds binds in the
canonic manner to the zinc ion and interacts with Thr199, Glu106, and Thr200.
The substituted phenyl tail of the second inhibitor was positioned in the
hydrophobic part of the binding pocket, at van der Waals distance from Phe131,
Val 135, Val141, Leu198, Pro202, and Leu204. These structures may help in the
design of better inhibitors of these widespread zinc-containing enzymes.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
J.Liu,
D.Obando,
V.Liao,
T.Lifa,
and
R.Codd
(2011).
The many faces of the adamantyl group in drug design.
|
| |
Eur J Med Chem,
46,
1949-1963.
|
 |
|
|
|
|
 |
H.Park,
S.Kim,
Y.E.Kim,
and
S.J.Lim
(2010).
A structure-based virtual screening approach toward the discovery of histone deacetylase inhibitors: identification of promising zinc-chelating groups.
|
| |
ChemMedChem,
5,
591-597.
|
 |
|
|
|
|
 |
V.M.Krishnamurthy,
G.K.Kaufman,
A.R.Urbach,
I.Gitlin,
K.L.Gudiksen,
D.B.Weibel,
and
G.M.Whitesides
(2008).
Carbonic anhydrase as a model for biophysical and physical-organic studies of proteins and protein-ligand binding.
|
| |
Chem Rev,
108,
946.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
|
');
}
}
 |